Sunday, 3 December 2017
It is pay-off time for investment in biosimilars: Kiran Mazumdar Shaw, Biocon
In an interview with ET Now, Kiran Mazumdar Shaw , CMD, Biocon , says it has been a huge investment for both Mylan and Biocon but it is now going to pay off both the companies and we look forward to basically getting a sizeable market share.
You can read more here: It is pay-off time for investment in biosimilars: Kiran Mazumdar Shaw, Biocon
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment